FDA signs off on Merck’s cholesterol-lowering pill — the first oral treatment of its kind

The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary forms of the disease, which causes elevated levels of LDL. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
공식 발표 ↔ 진영별 보도
+1